Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).Shaan Dudani, Daniel Yick Chin Heng, M. Neil Reaume et al.|Journal of Clinical Oncology|2020Cited by 31
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A. Bjarnason, Naveen S. Basappa, Jennifer J. Knox et al.|European Journal of Cancer|2019Cited by 28
Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.Steven Yip, Daniel Yick Chin Heng, Connor Wells et al.|Journal of Clinical Oncology|2017Cited by 12
Application of IMDC criteria across first-line (1L) and second-line (2L) therapies in metastatic renal-cell carcinoma (mRCC): New and updated benchmarks of clinical outcomes.Shaan Dudani, Daniel Yick Chin Heng, Chun Loo Gan et al.|Journal of Clinical Oncology|2020Cited by 11
Factors Influencing a Specific Pathologic Diagnosis of Non–Small-Cell Lung CarcinomaJeffrey Sulpher, Paul Wheatley‐Price, Scott Owen et al.|Clinical Lung Cancer|2013Cited by 8